David Younger

David Younger

Chief Executive Officer & Co-Founder at A-Alpha Bio
Seattle, Washington, United States

David Younger is the Co-Founder and CEO of A-Alpha Bio, a Seattle-based biotechnology company applying synthetic biology and machine learning to engineer and predict protein-protein interactions. He is a co-inventor of the AlphaSeq platform, which enables quantitative measurements used in therapeutic antibody and molecular glue discovery. He previously worked as a postdoctoral researcher at the University of Washington.

  • A-Alpha Bio logo
    A-Alpha Bio Executive Officer, Director 2019–present, Chief Executive Officer & Co-Founder 2017–present · current
  • University of Washington logo
    University of Washington Postdoctoral Researcher 2017–2018, Bioengineering Graduate Student 2012–2017 · past
  • Luminex Corporation Engineering Intern 2011 · past
  • Seattle Biomedical Research Institute Intern 2007 · past

Education

  • University of Washington Doctor of Philosophy (PhD), Bioengineering · 2012–2017
  • Rice University Bachelor of Science; Bachelor of Arts, Bioengineering, Economics · 2007–2012
  • The London School of Economics and Political Science (LSE) Economics · 2009–2010

Online